Literature DB >> 19398565

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

Michel Meignan, Emmanuel Itti, Stéphane Bardet, Jean Lumbroso, Véronique Edeline, Pierre Olivier, Thierry Vander Borght, Oumedaly Reman, Gilles Karcher, Olivier Mundler, Nicolas Mounier, Romain Ricci, Massimo Federico, John Raemaekers, Marc André.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19398565     DOI： 10.1200/JCO.2009.22.4089

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

Review 1.  PET/CT adapted therapy in Hodgkin disease: current state of the art and future directions.

Authors:  Eldad J Dann
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

2.  A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.

Authors:  Eldad J Dann; Rachel Bar-Shalom; Ada Tamir; Ron Epelbaum; Irit Avivi; Menachem Ben-Shachar; Diana Gaitini; Jacob M Rowe
Journal:  Haematologica       Date:  2010-04-21       Impact factor: 9.941

3.  An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

Authors:  Emmanuel Itti; Michel Meignan; Alina Berriolo-Riedinger; Alberto Biggi; Amanda F Cashen; Pierre Véra; Hervé Tilly; Barry A Siegel; Andrea Gallamini; René-Olivier Casasnovas; Corinne Haioun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-07       Impact factor: 9.236

4.  The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.

Authors:  Andrea Gallamini; Sally F Barrington; Alberto Biggi; Stephane Chauvie; Lale Kostakoglu; Michele Gregianin; Michel Meignan; George N Mikhaeel; Annika Loft; Jan M Zaucha; John F Seymour; Michael S Hofman; Luigi Rigacci; Alessandro Pulsoni; Morton Coleman; Eldad J Dann; Livio Trentin; Olivier Casasnovas; Chiara Rusconi; Pauline Brice; Silvia Bolis; Simonetta Viviani; Flavia Salvi; Stefano Luminari; Martin Hutchings
Journal:  Haematologica       Date:  2014-03-21       Impact factor: 9.941

5.  PET-guided clinical trials in Hodgkin lymphoma: to agree or not to agree, that is the reviewer's question.

Authors:  A Gallamini; M Meignan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-12       Impact factor: 9.236

6.  Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Authors:  Sally F Barrington; N George Mikhaeel; Lale Kostakoglu; Michel Meignan; Martin Hutchings; Stefan P Müeller; Lawrence H Schwartz; Emanuele Zucca; Richard I Fisher; Judith Trotman; Otto S Hoekstra; Rodney J Hicks; Michael J O'Doherty; Roland Hustinx; Alberto Biggi; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

Review 7.  Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.

Authors:  Bijal D Shah; Peter Martin; Eduardo M Sotomayor
Journal:  Cancer Control       Date:  2012-07       Impact factor: 3.302

8.  Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.

Authors:  Olivier Fitoussi; Karim Belhadj; Nicolas Mounier; Marie Parrens; Hervé Tilly; Gilles Salles; Pierre Feugier; Christophe Ferme; Loic Ysebaert; Jean Gabarre; Raoul Herbrecht; Maud Janvier; Eric Van Den Neste; Franck Morschhauser; Olivier Casasnovas; Hervé Ghesquieres; Bruno Anglaret; Sabine Brechignac; Corinne Haioun; Christian Gisselbrecht
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

Review 9.  Positron emission tomographic scans in lymphoma: convention and controversy.

Authors:  Stephen M Ansell; James O Armitage
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

10.  Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.

Authors:  Angela Aldin; Lisa Umlauff; Lise J Estcourt; Gary Collins; Karel Gm Moons; Andreas Engert; Carsten Kobe; Bastian von Tresckow; Madhuri Haque; Farid Foroutan; Nina Kreuzberger; Marialena Trivella; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2019-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.